Singapore · Biotechnology

ASLAN Pharmaceuticals

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Public · NASDAQ:ASLNFor profit

BiotechnologySingapore, Singapore

Against its peers

Set against 55 Biotechnology companies in Singapore. The ring marks the typical peer.

Staff11-50The typical size for its peers
Founded20101 year before the typical peer (2011)
Website traffic#1.6MBusier than the typical peer's site (#8.6M)

Across all 5.9M companies: larger than 33% of those with a size listed; older than 5% of those with a founding year; website ranked #1,588,125 in the world, about 15k visits a month.

About ASLAN Pharmaceuticals

What it does

BiotechnologyHealth CareMedicalOncologyPharmaceutical

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$186M

raised in total, currency not stated across 10 rounds

Last raised Mar 2024, 2 years ago

Rounds
10
Latest round
Post ipo equity
Investors
174 leading

Key facts

Who started it and how it trades.

Founded by
Carl Firth

Every detail we hold

Everything the source datasets list about ASLAN Pharmaceuticals, field by field. Contact details are held but never shown.

The company7 fields

Name
ASLAN Pharmaceuticals
Type
For profit
Status
Public · NASDAQ:ASLN
Founded
2010
Founders
Carl Firth
Industry
Biotechnology
Categories
Biotechnology, Health Care, Medical, Oncology, Pharmaceutical

Where3 fields

City
Singapore
Country
Singapore
Markets
Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia

Size and reach3 fields

Staff band
11-50
Web traffic rank
#1,588,125
Monthly web visits
14,871
Show 10 more fieldsShow fewer fields

Funding, as listed8 fields

Total
186,000,000 (currency not stated)
Rounds
10
Latest round
Post ipo equity
Latest round date
Mar 2024
Investors
17
Lead investors
4
Stock listing
NASDAQ:ASLN
Listing status
public

About this record2 fields

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

ASLAN Pharmaceuticals faced delisting from Nasdaq.

Companies like ASLAN Pharmaceuticals

Biotechnology in Singapore.

Build a lead list

55 Biotechnology companies in Singapore, filtered by size, age and reach, ready to export with emails on Pro.

Open the list